NovaBridge Biosciences American Depositary Shares (NBP) Stock Price

NBPStock

$1.26−80.79%52W

Market Cap$146.16M

P/E—

PEG Ratio—

Div yield—

Beta1.70

NBP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-60.30%

Price vs S&P 500 (4W)-20.41%

VGM Score24.15

Book Value / Share (Quarterly)$0.75

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-73.83%

Cash Flow / Share (Quarterly)$-0.20

Price vs S&P 500 (YTD)-80.27%

Gross Margin (TTM)100.00%

Net Profit Margin (TTM)-439.76%

EPS (TTM)$-0.19

10-Day Avg Trading Volume0.36M

EPS Excl Extra (TTM)$-0.19

Revenue Growth (5Y)-12.47%

EPS (Annual)$-0.21

ROI (Annual)-20.03%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-1791.81%

Cash / Share (Quarterly)$0.72

ROA (Last FY)-17.76%

EBITD / Share (TTM)$-0.32

ROE (5Y Avg)-50.80%

Operating Margin (TTM)-416.50%

Cash Flow / Share (Annual)$-0.08

P/B Ratio0.74x

P/B Ratio (Quarterly)1.12x

Net Income / Employee (Annual)$-1,542,300

Net Interest Coverage (TTM)-6.29x

ROA (TTM)-19.41%

EPS Incl Extra (Annual)$-0.21

Current Ratio (Annual)8.09x

Quick Ratio (Quarterly)7.60x

3-Month Avg Trading Volume0.48M

52-Week Price Return-80.79%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)5.41x

Asset Turnover (Annual)0.07x

52-Week High$6.79

Operating Margin (5Y Avg)-1670.60%

EPS Excl Extra (Annual)$-0.21

CapEx CAGR (5Y)-75.54%

26-Week Price Return-50.39%

Quick Ratio (Annual)8.06x

13-Week Price Return-29.21%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.64x

Enterprise Value$-41.00M

Revenue / Share Growth (5Y)-18.84%

Asset Turnover (TTM)0.11x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-297.41%

Cash / Share (Annual)$0.79

3-Month Return Std Dev45.25%

Net Income / Employee (TTM)$-1,542,300

ROE (Last FY)-20.03%

Net Interest Coverage (Annual)-2.57x

EPS Basic Excl Extra (Annual)$-0.21

Receivables Turnover (TTM)-1.54x

EV / Free Cash Flow (TTM)0.85x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.19

Receivables Turnover (Annual)-1.54x

ROI (TTM)-20.91%

P/S Ratio (TTM)3.16x

Pretax Margin (5Y Avg)-1700.94%

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-96.32%

Year-to-Date Return-68.34%

5-Day Price Return-4.55%

EPS Normalized (Annual)$-0.21

ROA (5Y Avg)-37.54%

Net Profit Margin (Annual)-751.44%

Month-to-Date Return-7.69%

EBITD / Share (Annual)$-0.43

Operating Margin (Annual)-260.52%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-50.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.19

P/B Ratio (Annual)1.98x

Pretax Margin (TTM)-439.76%

Book Value / Share (Annual)$0.87

Price vs S&P 500 (13W)-31.90%

Beta1.70x

P/FCF (Annual)0.35x

Revenue / Share (TTM)$0.00

ROE (TTM)-20.91%

52-Week Low$1.26

gGradeF

mGradeD

vgmGradeD

NBP Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2025	Apr 7, 2026	-$0.08	-$0.31	-287.50%(-$0.23)
Q3 2025	Dec 18, 2025	-$0.05	-$0.06	-20.00%(-$0.01)
Q2 2025	Aug 20, 2025	-$0.12	-$0.07	+41.67%(+$0.05)
Q1 2025	May 15, 2025	-$0.07	-$0.04	+38.46%(+$0.03)

NBP Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.22

4.25

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
NBPNovaBridge Biosciences American Depositary Shares	—	F	D	3.2x	—	100.0%	—	$1.26
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences is a biotechnology company that identifies and develops pharmaceutical assets, combining clinical research with strategic business development to advance therapies toward commercialization. The company's pipeline includes Givastomig, VIS-101, Ragistomig, and Uliledlimab.

NBP Insider Transactions

SellSep 18, 2026
DENNIS PHILIP ANDREW
Officer
Shares: 8,209Value: $13,134
SellSep 9, 2026
WUXIONG CAO SEAN
Officer
Shares: 107,978Value: $183,563
SellAug 31, 2026
XU CONG CLAIRE
Officer
Shares: 3,282Value: $5,973

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

DTILPrecision BioSciences, Inc. Common StockBiological Products
CMPXCompass Therapeutics, Inc. Common StockBiological Products
MDWDMediWound Ltd.Pharmaceutical Preparations
CHRSCoherus Oncology, Inc. Common StockBiological Products
NNNNAnbio Biotechnology Class A Ordinary SharesIn Vitro Diagnostics
TARAProtara Therapeutics, Inc. Common StockBiological Products
MOLNMolecular Partners AG American Depositary SharesBiological Products
LODEComstock Inc.Industrial Chemicals

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$1.26

High$6.79